Company:  AMGEN INC (AMGN)
Form Type:  10-Q
Filing Date:  11/6/2012 
CIK:  0000318154 
Address:  ONE AMGEN CENTER DRIVE 
City, State, Zip:  THOUSAND OAKS, California 91320 
Telephone:  (805)447-1000 
Fiscal Year:  12/31 
Last Trade
Last Trade: 
$113.72  
Change: 
0.405 (0.36%)  
Trade Time: 
04:00 PM EST  
Market Cap: 
$86.09B
Description of Business
Amgen Inc. (including its subsidiaries, referred to as �Amgen,� �the Company,� �we,� �our� or �us�) is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer, Amgen has grown to be the world's largest independent biotechnology company, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. We were incorporated in California in 1980 and became a Delaware corporation in 1987.
Register for EDGAR Pro and access this filing in:     
  FORM 10-Q
    PART I - FINANCIAL INFORMATION
      Item 1. FINANCIAL STATEMENTS
        INCOME STATEMENT
        BALANCE SHEET
        CASH FLOW
        NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
      Item 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL ...
      Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT ...
      Item 4. CONTROLS AND PROCEDURES
    PART II - OTHER INFORMATION
      Item 1. LEGAL PROCEEDINGS
      Item 1A. RISK FACTORS
      Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF ...
      Item 6. EXHIBITS
    SIGNATURES
    INDEX TO EXHIBITS
  EXHIBIT 10.2
  EXHIBIT 10.3
  EXHIBIT 10.13
  EXHIBIT 10.22
  EXHIBIT 31
    CERTIFICATIONS
  EXHIBIT 32
BROKERAGE PARTNERS